by Kathleen Gonzalez | Feb 25, 2019 | Blog
What’s Wrong With This Picture? No, not that one! (But yes, our 20th birthday was last year)… This one: a recent article published in Nature about a de novo IL-2 mimetic. Interleukin-2 (IL-2) is a potent anti-cancer treatment that stimulates the immune...
by Kathleen Gonzalez | Jan 11, 2019 | Blog
What’s Cool in 2019? You! (OK, Your HLA) 2018 brought us the magnificent microbiome, gene-edited pigs and ethical debate about gene-editing people. What are your predictions for 2019? We think that global warming will get worse, and that immunoinformatics will...
by Annie De Groot | Oct 23, 2018 | Blog, News
Leslie J. DeGroot MD (“Les”) was born in Fort Edward NY in 1928, dedicated his life to thyroid disease research and endocrinology and died soon after his 90th birthday, on October 23, 2018 in Nonquitt, Massachusetts,...
by Kathleen Gonzalez | Oct 2, 2018 | Blog, News
Revolutionizing Risk Assessment: Generic Peptide Drugs and Their Impurities EpiVax has been awarded a $1 million contract from the Food and Drug Administration (FDA) to demonstrate and validate the best practices and procedures for assessing generic peptide drugs and...
by Kathleen Gonzalez | Aug 14, 2018 | Blog
One-on-One Interview with Brian Roberts: Protein Therapeutics Manager at EpiVax We recently sat down with our very own Protein Therapeutics Manager, Brian Roberts, to discuss his ongoing work with PANDA. In this exclusive interview, he shares what his job entails and...
by Annie De Groot | Aug 6, 2018 | Blog
The beginning, and why we go : A look back at to February 2003, trip to Bamako A Travelogue by Annie De Groot, M.D. Dr. Annie De Groot and her associate Julie McMurry traveled to Bamako, Mali in January in 2003 to visit an AIDS vaccine clinical trial site. In 2002,...
